Angioplasty Balloons and Stents Market Outlook, Trends And Future Opportunities (2024-2031)

Angioplasty Balloons and Stents Market Outlook, Trends And Future Opportunities (2024-2031)

Angioplasty Balloons and Stents Market, By Product Type (Angioplasty Balloons, Plain Old Balloon Angioplasty (POBA) Balloons, Drug-Eluting Balloons, Cutting/Scoring Balloons, Others (e.g., Specialty Balloons), Coronary Stents, Bare-Metal Stents, Drug-Eluting Stents, Bioresorbable Stents, Peripheral Stents, Nitinol Stents, Balloon-Expandable Stents, Others (e.g., Covered Stents)), By End-User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Others (e.g., Private Clinics)), By Material (Metallic, Stainless Steel, Cobalt-Chromium, Platinum-Chromium, Polymer, Polyethylene Terephthalate (PET), Polyurethane, Others (e.g., Nylon, PEBAX)), By Coating (Drug-Eluting, Paclitaxel-Eluting, Sirolimus-Eluting, Everolimus-Eluting, Non-Drug-Eluting, Heparin-Coated, Hydroxy-Apatite Coated, Others (e.g., Polyzene-F Coated)), By Application (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease, Others (e.g., Renal Artery Disease)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Apr 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA124
  • Region: Global
  • Format: PDF/EXCEL

Table Of Contents:

Chapter 1. Research Methodology and Scope

  • Market Segmentation and Scope
  • Regional Coverage
  • Objectives
  • Research Methodology

Chapter 2. Executive Summary

  • Market Landscape
  • Market Size & Forecast
  • Competitive Landscape

Chapter 3. Angioplasty Balloons and Stents Market: Angioplasty Balloons Trends, Size, and Future Outlook

  • Angioplasty Balloons Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Angioplasty Balloons Definitions, Technology Landscape
  • Angioplasty Balloons Market Drivers
    • Product Launches
    • Technology Launches
    • Rising prevalence of cardiovascular diseases
    • Advancements in balloon technology
  • Angioplasty Balloons Market Restraints
    • High cost of advanced angioplasty devices
    • Stringent regulatory requirements

Chapter 4. Angioplasty Balloons and Stents Market: Coronary Stents Trends, Size, and Future Outlook

  • Coronary Stents Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Coronary Stents Definitions, Technology Landscape
  • Coronary Stents Market Drivers
    • Increasing adoption of minimally invasive procedures
    • Advancements in stent technology
  • Coronary Stents Market Restraints
    • Risks associated with angioplasty procedures
    • Reimbursement challenges

Chapter 5. Angioplasty Balloons and Stents Market: Peripheral Stents Trends, Size, and Future Outlook

  • Peripheral Stents Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • Peripheral Stents Definitions, Technology Landscape
  • Peripheral Stents Market Drivers
    • Growing prevalence of peripheral artery disease
    • Technological innovations in stent design
  • Peripheral Stents Market Restraints
    • Limited accessibility in developing regions
    • Complications associated with peripheral interventions

Chapter 6. Angioplasty Balloons and Stents Market: By End-User Trends, Size, and Future Outlook

  • End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • End-User Definitions, Technology Landscape
  • End-User Market Drivers
    • Increasing adoption of minimally invasive procedures in hospitals
    • Rising demand for advanced treatment options in specialized centers
  • End-User Market Restraints
    • Reimbursement challenges for certain end-users
    • Limited infrastructure in rural and remote areas

Chapter 7. Angioplasty Balloons and Stents Market: Regional Market Trends, Size, and Future Outlook

  • North America Trends, Market Size (US$), CAGR (%), and Future Outlook
  • North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
  • North America Definitions, Technology Landscape
  • North America Market Drivers
    • High prevalence of cardiovascular diseases
    • Presence of well-established healthcare infrastructure
    • Strong presence of key market players
  • North America Market Restraints
    • High cost of advanced angioplasty devices
    • Reimbursement challenges in certain regions
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East, and Africa

Chapter 8. Angioplasty Balloons and Stents Market: Competitive Landscape

  • Abbott Laboratories
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Medtronic plc
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Cordis (a Cardinal Health company)
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Terumo Corporation
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Cook Medical
  • Meril Life Sciences Pvt. Ltd.
  • Biosensors International Group, Ltd.
  • Microport Scientific Corporation
  • Spectranetics Corporation
  • Alvimedica Medical Devices
  • Endologix, Inc.
  • Translumina GmbH
  • Hexacath
  • Clearstream Technologies Ltd.
  • Rontis Medical
  • Bentley (subsidiary of B. Braun Melsungen AG)
  • Elixir Medical Corporation

Research Methodology

  • Primary Research
  • Secondary Research
  • Assumptions
  • IDataAcumen Analysis
  • Paid Databases

Appendix

  • About Us

Frequently Asked Questions

The current market size of the Angioplasty Balloons and Stents industry is US$ 9,675 million in 2023.

The key factors driving the growth of the Angioplasty Balloons and Stents market include the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, advancements in stent and balloon technology, and the aging global population.

The key factors hampering the growth of the Angioplasty Balloons and Stents market include the risks associated with angioplasty procedures, the high costs of advanced angioplasty devices, stringent regulatory requirements, and reimbursement challenges.

The leading component segment in the Angioplasty Balloons and Stents Market is the Coronary Stents segment, which includes drug-eluting stents, bare-metal stents, and bioresorbable stents, and is used to treat coronary artery disease.

The major players operating in the Angioplasty Balloons and Stents Market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis (a Cardinal Health company), Terumo Corporation, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical, Meril Life Sciences Pvt. Ltd., and Biosensors International Group, Ltd., among others.

The Angioplasty Balloons and Stents Market is expected to grow at a CAGR of 5.8% from 2024 to 2031, reaching a market size of US$ 15,189.2 million by 2031.

The key drivers of the Angioplasty Balloons and Stents Market include the rising prevalence of cardiovascular diseases, the increasing adoption of minimally invasive procedures, advancements in stent and balloon technology, the growing geriatric population, the focus on drug-eluting and bioresorbable devices, the integration of artificial intelligence and machine learning, the increasing demand for peripheral angioplasty, and the shift towards value-based healthcare.